Welcome to our dedicated page for QTREX Quantum Ltd. SEC filings (Ticker: QTEXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on QTREX Quantum Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into QTREX Quantum Ltd.'s regulatory disclosures and financial reporting.
QTREX Quantum Ltd. announced a research collaboration with Northeastern University focused on advanced micro-system structures for cryogenic quantum interconnects. Under the collaboration agreement, Northeastern granted QTREX a first option to negotiate a commercial license to intellectual property arising directly from the joint research (Project IP). The program is intended to expand QTREX’s vertically integrated quantum connectivity platform by adding a structured innovation pipeline supporting new quantum connectivity architectures, including exploration of conductive, dielectric and superconducting materials under cryogenic conditions.
Joint teams have begun defining research objectives, aligning technical priorities and allocating responsibilities. The announcement reiterates QTREX’s strategy to combine proprietary materials, advanced manufacturing, processor-interface technologies and academic partnerships to build next-generation quantum connectivity solutions. Specified portions of this announcement are incorporated by reference into QTREX’s existing Form F-3 and Form S-8 registration statements, and the company notes that statements about the collaboration’s scope and potential outcomes are forward-looking and subject to risks described in its Form 20-F for the year ended December 31, 2025.
Qtrex Quantum Ltd. will hold an annual and extraordinary shareholder meeting on August 28, 2026 to vote on 11 proposals and review 2025 audited financial statements.
Items include re‑appointing the auditor, re‑electing four directors and electing one new director, adopting an updated three‑year compensation policy, and increasing pay and granting RSUs to the CEO, chairman and non‑executive directors. The CEO would receive a higher monthly fee and up to 550,000 RSUs; the chairman a higher annual fee and up to 550,000 RSUs; and two non‑executive directors a combined 270,000 RSUs.
Shareholders are also asked to increase authorized share capital from 100,000,000 to 300,000,000 Ordinary Shares and approve amended articles that introduce a staggered three‑class board, stricter removal and amendment thresholds, and permit protective measures such as a shareholder rights plan. Several compensation‑related items require a Special Majority of non‑controlling, disinterested shareholders.
QTREX Quantum Ltd. director Chappel-Ram Shlomit filed an initial statement of beneficial ownership on Form 3 in connection with QTEX. The filing lists no reportable transactions, and no equity or derivative holdings are reported, as reflected by zero transaction counts and zero holding entries.
Qtrex Quantum Ltd. reports that its board of directors approved an increase in ordinary shares reserved for issuance under its Amended and Restated 2019 Equity Incentive Plan by 3,834,244 shares, raising the reserve from 11,875,977 to 15,710,221 shares, following a decision dated July 6, 2026.
The company states that this Form 6-K is incorporated by reference into its existing Registration Statements on Form F-3 and Form S-8, so those shelf and employee-benefit registrations now reflect the expanded equity incentive plan share pool.
QTREX Quantum Ltd. reports that its Board of Directors appointed Dr. Shlomit Chappel-Ram as an independent director on July 14, 2026, effective immediately. She brings extensive Additively Manufactured Electronics (AME) and multidisciplinary R&D leadership experience, including prior service as Vice President of R&D at Nano Dimension Ltd.
The company recently acquired Nano Dimension’s AME platform in April 2026 and is developing high-density, thermally optimized quantum connectivity solutions and mission‑critical AME applications. QTREX also continues to advance and selectively monetize its medical technology portfolio. The release includes forward-looking statements regarding AME platform advances and Dr. Chappel-Ram’s expected contributions.
QTREX Quantum Ltd. has had its warrant class targeted for removal from listing and registration on the Nasdaq Stock Market LLC. Nasdaq filed a Form 25 under Section 12(b) of the Securities Exchange Act of 1934, referencing Rule 12d2-2, to strike this class of securities from listing and/or withdraw its registration.
shabtay abraham reported acquisition or exercise transactions in this Form 4 filing.
QTREX Quantum Ltd. granted COO Shabtay Abraham 550,000 equity units recorded as Ordinary Shares at an effective price of $0.0000 per share under the company’s 2019 plan. The grant consists of Restricted Share Units, with 183,334 RSUs vesting on July 1, 2027 and the remaining RSUs vesting quarterly over two years. After this award, he holds 1,882,713 ordinary shares directly.
Rozanovich Yoav reported acquisition or exercise transactions in this Form 4 filing.
QTREX Quantum Ltd. granted Chief Business Officer Yoav Rozanovich an equity award covering 550,000 Ordinary Shares on July 6, 2026, recorded at $0.0000 per share.
The award consists of Restricted Share Units, with 183,334 RSUs vesting on October 1, 2026 and the remaining RSUs vesting on a quarterly basis over two years after that date.
Yechezkely Hayon Daniella reported acquisition or exercise transactions in this Form 4 filing.
QTREX Quantum Ltd. granted its Chief Technology Officer, Daniella Yechezkely Hayon, an award of 550,000 restricted share units representing ordinary shares on July 6, 2026 at $0.00 per share. Following this grant, she reports ownership of 1,330,000 ordinary shares, held directly. The RSUs were granted under the company’s 2019 Plan, with 183,334 units vesting on July 1, 2027 and the remaining units vesting on a quarterly basis over two years after that date.
Tehila Yafit reported acquisition or exercise transactions in this Form 4 filing.
QTREX Quantum Ltd. granted Chief Financial Officer Tehila Yafit 550,000 Ordinary Shares as a compensation award at $0.0000 per share, increasing her direct holdings to 1,420,000 shares. The award is structured as Restricted Share Units that vest, including 183,334 RSUs on July 1, 2027, with the remaining RSUs vesting on a quarterly basis over the following two years.